Hernández Eric G, Granados Julio, Partida-Rodríguez Oswaldo, Valenzuela Olivia, Rascón Edgar, Magaña Ulises, Escamilla-Tilch Mónica, López-Reyes Alberto, Nieves-Ramírez Miriam, González Enrique, Morán Patricia, Rojas Liliana, Valadez Alicia, Luna Alexandra, Estrada Francisco J, Maldonado Carmen, Ximénez Cecilia
Laboratorio de Inmunología, Departamento de Medicina Experimental, Facultad de Medicina, UNAM, Mexico City, México.
División de Inmunogenética, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), SSa, Mexico City, México.
PLoS One. 2015 May 4;10(5):e0126195. doi: 10.1371/journal.pone.0126195. eCollection 2015.
Amebiasis is an endemic disease and a public health problem throughout Mexico, although the incidence rates of amebic liver abscess (ALA) vary among the geographic regions of the country. Notably, incidence rates are high in the northwestern states (especially Sonora with a rate of 12.57/100,000 inhabitants) compared with the central region (Mexico City with a rate of 0.69/100,000 inhabitants). These data may be related to host genetic factors that are partially responsible for resistance or susceptibility. Therefore, we studied the association of the HLA-DRB1 and HLA-DQB1 alleles with resistance or susceptibility to ALA in two Mexican populations, one each from Mexico City and Sonora. Ninety ALA patients were clinically diagnosed by serology and sonography. Genomic DNA was extracted from peripheral blood mononuclear cells. To establish the genetic identity of both populations, 15 short tandem repeats (STRs) were analyzed with multiplexed PCR, and the allelic frequencies of HLA were studied by PCR-SSO using LUMINEX technology. The allele frequencies obtained were compared to an ethnically matched healthy control group (146 individuals). We observed that both affected populations differed genetically from the control group. We also found interesting trends in the population from Mexico City. HLA-DQB102 allele frequencies were higher in ALA patients compared to the control group (0.127 vs 0.047; p= 0.01; pc= NS; OR= 2.9, 95% CI= 1.09-8.3). The less frequent alleles in ALA patients were HLA-DRB108 (0.118 vs 0.238 in controls; p= 0.01; pc= NS; OR= 0.42, 95% CI= 0.19-0.87) and HLA-DQB104 (0.109 vs 0.214; p= 0.02; pc= NS; OR= 0.40, 95% CI= 0.20-0.94). The haplotype HLA-DRB108/-DQB1*04 also demonstrated a protective trend against the development of this disease (0.081 vs. 0.178; p=0.02; pc=NS; OR= 0.40, 95% CI= 0.16-0.93). These trends suggest that the prevalent alleles in the population of Mexico City may be associated with protection against the development of ALA.
阿米巴病是墨西哥全国范围内的一种地方病和公共卫生问题,尽管该国不同地理区域的阿米巴肝脓肿(ALA)发病率有所不同。值得注意的是,与中部地区(墨西哥城发病率为0.69/10万居民)相比,西北部各州的发病率较高(特别是索诺拉州,发病率为12.57/10万居民)。这些数据可能与宿主遗传因素有关,这些因素部分导致了抵抗力或易感性。因此,我们研究了HLA-DRB1和HLA-DQB1等位基因与墨西哥两个群体对ALA的抵抗力或易感性之间的关联,一个群体来自墨西哥城,另一个来自索诺拉州。90例ALA患者通过血清学和超声检查进行临床诊断。从外周血单个核细胞中提取基因组DNA。为了确定两个群体的基因特征,使用多重PCR分析了15个短串联重复序列(STR),并使用LUMINEX技术通过PCR-SSO研究了HLA的等位基因频率。将获得的等位基因频率与种族匹配的健康对照组(146人)进行比较。我们观察到,两个患病群体在基因上与对照组不同。我们还在来自墨西哥城的群体中发现了有趣的趋势。与对照组相比,ALA患者中HLA-DQB102等位基因频率更高(0.127对0.047;p = 0.01;校正p值=无显著性差异;比值比=2.9,95%置信区间=1.09 - 8.3)。ALA患者中频率较低的等位基因是HLA-DRB108(对照组中为0.238,患者中为0.118;p = 0.01;校正p值=无显著性差异;比值比=0.42,95%置信区间=0.19 - 0.87)和HLA-DQB104(0.109对0.214;p = 0.02;校正p值=无显著性差异;比值比=0.40,95%置信区间=0.20 - 0.94)。单倍型HLA-DRB108/-DQB1*04也显示出对这种疾病发展的保护趋势(0.081对0.178;p = 0.02;校正p值=无显著性差异;比值比=0.40,95%置信区间=0.16 - 0.93)。这些趋势表明,墨西哥城群体中流行的等位基因可能与预防ALA的发生有关。